HOME >> MEDICINE >> NEWS
National Clinical Trial To Test Effectiveness Of Antibiotic Treatment For Coronary Artery Disease

Can heart disease -- the nation's number-one killer -- be effectively treated with antibiotics? A national clinical trial directed by the University of Washington and funded through an $11 million grant from the National Institutes of Health (National Heart, Lung and Blood Institute) and Pfizer Corporation will examine the effectiveness of antibiotic treatment for patients with coronary artery disease.

The Azithromycin and Cardiac Events Study (ACES) focuses on the role of a common bacterium, Chlamydia pneumoniae, that has been associated with atherosclerosis in humans. The study will be led by principal investigator

Dr. J. Thomas Grayston, a pioneer in chlamydia research and professor of epidemiology at the University of Washington School of Public Health and Community Medicine. Approximately 27 clinical centers nationwide will participate in the study.

"The idea of giving antibiotics to treat a chronic disease like coronary artery disease is not as farfetched an idea as it once was," said Grayston. "This clinical trial should help prove whether the Chlamydia pneumoniae bacteria plays a role in the cause of complications of atherosclerosis."

Chlamydia pneumoniae is a common cause of respiratory infections, including pneumonia and bronchitis. Nearly every person is infected with the bacteria at some time in life. In the late 1980s, researchers, including Grayston, identified a possible relationship between Chlamydia pneumoniae and heart disease when the bacteria was identified in samples of diseased coronary artery tissue.

Two small trials evaluating the use of antibiotics for patients with coronary artery disease showed some positive indications.

"This large-scale clinical trial will provide substantial evidence about whether antibiotics should be used in the treatment of coronary artery disease," Grayston said.

Participating research centers will enro
'"/>

Contact: Julie Rathbun
rath@u.washington.edu
206-543-3620
University of Washington
16-Nov-1998


Page: 1 2

Related medicine news :

1. National Academies advisory: May 2 Symposium on International Science Policy
2. National Academies News: William H. Foege to receive Public Welfare Medal, Academys highest honor
3. National Academies news: Academy honors 17 for major contributions to science
4. National Academies advisory: Report assesses health implications of perchlorate exposure
5. National Academies Advisory: Jan. 11 public briefing on perchlorate in drinking water
6. National Academies news: Gulf War and Health
7. National survey shows few physicians elected to Congress
8. Six new Roybal Centers for Applied Gerontology established by National Institute on Aging
9. UGA professor receives $3 million grant from National Cancer Institute for breast cancer research
10. National Academies advisory: Nov. 4-6 Frontiers of Science meeting in Irvine, Calif.
11. National Chemistry Week celebrates health and wellness in Washington, D.C., area

Post Your Comments:
(Date:3/4/2015)... San Jose, CA (PRWEB) March 04, 2015 ... products produced by companies whose management forgot – or ... assessing potential value: Validate the market based on physician ... “We've seen companies – more specifically, founders – become ... to answer the key question: Will physicians use the ...
(Date:3/3/2015)... As payers pledge to move the bulk ... next few years, they are testing various initiatives to ... care spending they control — involved. The March issue ... tracks some of the strategies proposed by industry ... organization (ACO)-type model. , One way to get specialists ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 NOVAtime ... of enterprise Time and Attendance / Workforce Management ... to NOVAtime SaaS Workforce Management / Time ... and attendance processes. , Since 2004, Innovative ... developmental disabilities with the best quality of life. ...
(Date:3/3/2015)... Loma Linda University Health announced today, that ... it will be offering new, healthier choices in all ... the past year, a cross-section of Loma Linda University ... listening to vendors, sampling their products, and ultimately recommending ... Most recently, a food fair was held during which ...
(Date:3/3/2015)... Sacramento, CA (PRWEB) March 03, 2015 ... cancers. , Researchers at UC Davis have developed and ... of cancer cells, causing them to self-destruct. This novel ... – responsible for a usually fatal type of brain ... aggressive cancers. , The article, to be published ...
Breaking Medicine News(10 mins):Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 2Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 3Health News:AIS Newsletter Examines Ways to Engage Specialists in Value-Based Payment Contracts 2Health News:AIS Newsletter Examines Ways to Engage Specialists in Value-Based Payment Contracts 3Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 2Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 3Health News:Loma Linda University Health Rejuvenates Its Vending Machines with Healthier Selections 2Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 2Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 3Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 4
(Date:3/3/2015)... BETHESDA, Md. , March 3, 2015 /PRNewswire/-- ViaCyte, ... stem cell-derived islet replacement therapy for the treatment of ... Dr. Eugene Brandon , Director of Strategic Relations ... annual summit showcases the latest in type 1 diabetes ... presentation are as follows: , , , ...
(Date:3/3/2015)... MOUNTAIN VIEW, Calif. , March 3, 2015 ... the enhanced drug discovery market, Frost & Sullivan ... Frost & Sullivan Award for Technology Leadership. Neopeutics ... offering clients a robust, cost-effective, and easily adaptable ... on agents that are catalogued as failing compounds ...
(Date:3/3/2015)... Colo. , March 3, 2015  Cannabis Science, ... development of cannabis-based medicine, today announced two important developments: ... its multiple global product launches, and CEO Raymond ... the Chicago HR Examiner. In the article, ... about leading a company in an industry that ...
Breaking Medicine Technology:ViaCyte to Present at JDRF TypeOneNation Research Summit 2Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 2Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 3Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 4Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 5CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 2CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 3CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 4CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 5
Cached News: